Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Clinical trial NCT01231685 · COMPLETED
Trial details
- NCT number
- NCT01231685
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.